Skip to main content

Advertisement

SpringerLink
Log in

Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Yeo W, Chan PK, Zhong S, Ho WM et al (2000) Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 62:299–307

    Article  CAS  PubMed  Google Scholar 

  2. Tsutsumi Y, Kanamori H, Mori A et al (2005) Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 4:599–608

    Article  CAS  PubMed  Google Scholar 

  3. Yeo W, Chan TC, Leung NW et al (2009) Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 27:605–611

    Article  CAS  PubMed  Google Scholar 

  4. Sera T, Hiasa Y, Michitaka K et al (2006) Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med 45(11):721–724

    Article  PubMed  Google Scholar 

  5. Furst DE (2008) The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum (Epub ahead of print)

  6. Zingarelli S, Ario P, Frassi M et al (2008) Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases. Reumatismo 60:22–27

    CAS  PubMed  Google Scholar 

  7. Nathan DM, Angus PW, Gibson PR (2006) Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach. J Gastroenterol Hepatol 21:1366–1371

    Article  CAS  PubMed  Google Scholar 

  8. Calabrese LH, Zein N, Vassilopoulos D (2004) Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis 63(Suppl 2):ii18–ii24

    Article  CAS  PubMed  Google Scholar 

  9. Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L (2006) Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondyloarthropathies with concurrent B or C chronic hepatitis. Rheumatology 45(10):1294–1297

    Article  CAS  PubMed  Google Scholar 

  10. Salliot C, Dougados M, Gossec L (2009) Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomized placebo-controlled trials. Ann Rheum Dis 68:25–32

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Propedeutic Department of Internal Medicine, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece

    Athina Pyrpasopoulou, Stella Douma, Themistoklis Vassiliadis, Sofia Chatzimichailidou, Areti Triantafyllou & Spyros Aslanidis

Authors
  1. Athina Pyrpasopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stella Douma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Themistoklis Vassiliadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sofia Chatzimichailidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Areti Triantafyllou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Spyros Aslanidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Spyros Aslanidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pyrpasopoulou, A., Douma, S., Vassiliadis, T. et al. Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis. Rheumatol Int 31, 403–404 (2011). https://doi.org/10.1007/s00296-009-1202-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1202-2

Keywords

Search

Navigation